Related references
Note: Only part of the references are listed.Human papillomavirus types 16 and 18 vaccine (Recombinant, AS04 adjuvanted, adsorbed) [Cervarix (TM)]
Susan J. Keam et al.
DRUGS (2008)
A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: Importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention
David Jenkins
GYNECOLOGIC ONCOLOGY (2008)
Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: Improving upon nature
Tino F. Schwarz et al.
GYNECOLOGIC ONCOLOGY (2008)
Impact of vaccination with Cervarix™ on subsequent HPV-16/18 infection and cervical disease in women 15-25 years of age
Diane M. Harper
GYNECOLOGIC ONCOLOGY (2008)
Human papillomavirus vaccination - Reasons for caution
Charlotte J. Haug
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Health and economic implications of HPV vaccination in the United States
Jane J. Kim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Introduction of Human Papillomavirus Vaccines into Developing Countries - International Strategies for Funding and Procurement
Jon Kim Andrus et al.
VACCINE (2008)
HPV: from infection to cancer
M. A. Stanley et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection - A randomized trial
Allan Hildesheim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition
Patricia M. Day et al.
JOURNAL OF VIROLOGY (2007)
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women:: an interim analysis of a phase III double-blind, randomised controlled trial
Jorma Paavonen et al.
LANCET (2007)
Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like pailicle vaccine containing AS04 adjuvant
Court Pedersen et al.
JOURNAL OF ADOLESCENT HEALTH (2007)
Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only
Sandra L. Giannini et al.
VACCINE (2006)
Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
DM Harper et al.
LANCET (2006)
Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors:: Implications for screening and prevention
X Castellsagué et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines
F Méndez et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
The epidemiology of human papillomavirus infections
JG Baseman et al.
JOURNAL OF CLINICAL VIROLOGY (2005)
Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women
S Bulk et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Against which human papillomavirus types shall we vaccinate and screen?: The international perspective
N Muñoz et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population
KS Cuschieri et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
DM Harper et al.
LANCET (2004)
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The causal relation between human papillomavirus and cervical cancer
FX Bosch et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Factors predicting disease outcome in early stage adenocarcinoma of the uterine cervix
M Erzen et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2002)
Adenocarcinoma of the uterine cervix compared with squamous cell carcinoma: a 12-year study in Southampton and South-west Hampshire
A Herbert et al.
CYTOPATHOLOGY (2001)
The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States - A 24-year population-based study
HO Smith et al.
GYNECOLOGIC ONCOLOGY (2000)
Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection
JJ Carter et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
